# EDGAR Filing Document

**Accession Number:** 0001633927
**File Stem:** 0001493152-26-020941
**Filing Date:** 2026-5
**Character Count:** 12894
**Document Hash:** 17758385b97674549c5612c7c0ed0aa9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-020941.hdr.sgml**: 20260501

**ACCESSION NUMBER**: 0001493152-26-020941

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260501

**DATE AS OF CHANGE**: 20260501

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hepion Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001583771
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 462783806
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-87637
- **FILM NUMBER:** 26933915

**BUSINESS ADDRESS:**
- **STREET 1:** 34 SHREWSBURY AVE.
- **STREET 2:** SUITE 1D
- **CITY:** RED BANK
- **STATE:** NJ
- **ZIP:** 07701
- **BUSINESS PHONE:** 732-902-4000

**MAIL ADDRESS:**
- **STREET 1:** 34 SHREWSBURY AVE.
- **STREET 2:** SUITE 1D
- **CITY:** RED BANK
- **STATE:** NJ
- **ZIP:** 07701

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ContraVir Pharmaceuticals, Inc.
- **DATE OF NAME CHANGE:** 20130806
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LoPriore Vincent S
- **CENTRAL INDEX KEY:** 0001633927

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **STREET 1:** 40 WALL STREET, 30TH FLOOR
- **STREET 2:** C/O CENTRAL PARK ADVISORS, LLC
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10005

## Ex-1

**Exhibit 1**

**JOINT FILING AGREEMENT**

This Joint Filing Agreement is by and between Vincent LoPriore, Gravitas Capital LP and Invictus Capital Advisors Pension Plan (collectively, the "Filers").

Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13D with respect to shares of common stock of Hepion Pharmaceuticals, Inc. beneficially owned by them from time to time.

Pursuant to and in accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the Filers hereby agree to file a single statement on Schedule 13D (and any amendments thereto) on behalf of each of the Filers, and hereby further agree to file this Joint Filing Agreement as an exhibit to such statement, as required by such rule.

This Joint Filing Agreement may be terminated by any of the Filers upon seven days prior written notice or such lesser period of notice as the Filers may mutually agree.

Executed and delivered as of the date first above written.

---

| | | |
|:---|:---|:---|
| Dated: May 1, 2026 | By: | /s/ Vincent LoPriore |
|  | Name: | Vincent LoPriore |
|  | **Gravitas Capital LP** | **Gravitas Capital LP** |
|  | By: | /s/ Vincent LoPriore |
|  | Name: | Vincent LoPriore |
|  | Title: | Managing Member |
|  | **Invictus Capital Advisors Pension Plan** | **Invictus Capital Advisors Pension Plan** |
|  | By: | /s/ Vincent LoPriore |
|  | Name: | Vincent LoPriore |
|  | Title: | Trustee |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Hepion Pharmaceuticals, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Vincent LoPriore**<br>c/o Hepion Pharmaceuticals, inc.,<br>34 Shrewsbury Ave., Suite 1D<br>Red Bank NJ 07701<br>(732) 902-4000

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**04/21/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Gravitas Capital LP** | Name of reporting person<br>**Gravitas Capital LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**5000000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**5000000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**5000000.00** | Aggregate amount beneficially owned by each reporting person<br>**5000000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**17.17%** | Percent of class represented by amount in Row (11)<br>**17.17%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** (1) The percentage reported in row 13 above is calculated with a numerator of 5,000,000 shares beneficially owned by the reporting person and a denominator of 29,119,317 shares of Common Stock outstanding as of April 21, 2026.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Invictus Capital Advisors Pension Plan** | Name of reporting person<br>**Invictus Capital Advisors Pension Plan** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**1250000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**1250000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1250000.00** | Aggregate amount beneficially owned by each reporting person<br>**1250000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**4.29%** | Percent of class represented by amount in Row (11)<br>**4.29%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** (1) The percentage reported in row 13 above is calculated with a numerator of 1,250,000 shares beneficially owned by the reporting person and a denominator of 29,119,317 shares of Common Stock outstanding as of April 21, 2026.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Vincent LoPriore** | Name of reporting person<br>**Vincent LoPriore** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**1250000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**5000000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**1250000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**5000000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6250000.00** | Aggregate amount beneficially owned by each reporting person<br>**6250000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**21.46%** | Percent of class represented by amount in Row (11)<br>**21.46%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** (1) The percentage reported in row 13 above is calculated with a numerator of 6,250,000 shares beneficially owned by the reporting person and a denominator of 29,119,317 shares of Common Stock outstanding as of April 21, 2026.

Vincent LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the 5,000,000 shares of Common Stock held by Gravitas Capital LP. Mr. LoPriore is the trustee and beneficiary of the Invictus Capital Advisors Pension Plan (the "Pension Plan") and in such capacity has the right to vote and dispose of the 1,250,000 shares of Common Stock held by the Pension Plan.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**(b) Name of Issuer:**
Hepion Pharmaceuticals, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
c/o Hepion Pharmaceuticals, Inc.,, 34 Shrewsbury Ave., Suite 1D, Red Bank, NJ, 07701

**Item 4. Purpose of Transaction**

The Common Stock owned by each of the Reporting Persons has been acquired for investment purposes. The Reporting Person may make further acquisitions of the Common Stock from time to time. Except for the foregoing, the Reporting Persons have no plans or proposals which relate to, or could result in, any of the matters referred to in Item 4 of Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
See responses to Items 11 and 13 on the cover pages for each Reporting Person.

**(b)**
See responses to Items 7, 8, 9 and 10 on the cover pages for each Reporting Person.

**(c)**
Not applicable.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Other than as described herein, each of the Reporting Persons do not have any contracts, arrangements, understandings or relationships with respect to the securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Gravitas Capital LP

**Signature:** /s/ Vincent LoPriore

**Name/Title:** Vincent LoPriore

**Date:** 05/01/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Invictus Capital Advisors Pension Plan

**Signature:** /s/ Vincent LoPriore

**Name/Title:** Vincent LoPriore/ Managing Member

**Date:** 05/01/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Vincent LoPriore

**Signature:** /s/ Vincent LoPriore

**Name/Title:** Vincent LoPriore/ Trustee

**Date:** 05/01/2026